איקסמפרה 15 מ"ג

Land: Israel

Sprog: hebraisk

Kilde: Ministry of Health

Aktiv bestanddel:

IXABEPILONE 15 MG

Tilgængelig fra:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC-kode:

L01DC04

Lægemiddelform:

POWDER FOR CONCENTRATE FOR INFUSION

Indgivelsesvej:

I.V

Fremstillet af:

CORDEN PHARMA LATINA S.P.A., ITALY

Terapeutisk gruppe:

IXABEPILONE

Terapeutiske indikationer:

Ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:In combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.As monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom futher anthracycline therapy is not indicated.

Autorisation dato:

2012-01-01